SQUALAMINE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Squalamine is a chemical found in the stomach and liver of the spiny dogfish shark. Squalamine can also be made in the lab.

Squalamine is a chemical called an aminosterol. It has effects that might prevent bacteria from growing and causing infections. It also might prevent the growth of tumors.

People use squalamine for age-related vision loss, lung cancer, ringworm, and many other conditions, but there is no good scientific evidence to support these uses.

Don't confuse squalamine with shark cartilage or shark liver oil. These contain squalamine but they are not the same.

Uses & Effectiveness

We currently have no information for SQUALAMINE overview.

Side Effects

When taken by mouth: There isn't enough reliable information to know if squalamine is safe or what the side effects might be.

When applied into the eye: Squalamine eye drops are possibly safe when used twice daily for up to 38 weeks. It seems to be well-tolerated.

Special Precautions and Warnings

Pregnancy and breast-feeding: There isn't enough reliable information to know if squalamine is safe when used while pregnant or breast-feeding. Stay on the safe side and avoid use.

Children: Squalamine is possibly safe in children 6-15 years-old when applied to the scalp in a lotion once daily for up to 3 weeks.

Interactions

We currently have no information for SQUALAMINE overview.

Dosing

There isn't enough reliable information to know what an appropriate dose of squalamine might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.

View References

REFERENCES:

Jiang, B., Liu, J. H., Bao, Y. M., and An, L. J. Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin. Cell Biol.Int 2003;27(12):1025-1031. View abstract.

Jiang, R. W., Lau, K. M., Lam, H. M., Yam, W. S., Leung, L. K., Choi, K. L., Waye, M. M., Mak, T. C., Woo, K. S., and Fung, K. P. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J Ethnopharmacol. 1-4-2005;96(1-2):133-138. View abstract.

Jiang, X. X., Li, Y., and Wu, Y. B. [Effect of puerarin preconditioning on cytokine levels in patients undergoing cardiopulmonary bypass in perioperative period]. Zhongguo Zhong.Xi.Yi Jie.He.Za Zhi 2009;29(12):1089-1091. View abstract.

Jin, W. S., Tan, Y. Y., Chen, Y. G., and Wang, Y. [Determination of puerarin, daidzin and daidzein in root of Pueraria lobata of different origin by HPLC]. Zhongguo Zhong.Yao Za Zhi. 2003;28(1):49-51. View abstract.

Kamiya, T., Takano, A., Matsuzuka, Y., Kusaba, N., Ikeguchi, M., Takagaki, K., and Kondo, K. Consumption of Pueraria flower extract reduces body mass index via a decrease in the visceral fat area in obese humans. Biosci.Biotechnol.Biochem. 2012;76(8):1511-1517. View abstract.

Kang, R. X. [The intraocular pressure depressive effect of puerarin]. Zhonghua Yan.Ke.Za Zhi. 1993;29(6):336-339. View abstract.

Keung, W. M., Lazo, O., Kunze, L., and Vallee, B. L. Potentiation of the bioavailability of daidzin by an extract of Radix puerariae. Proc.Natl.Acad.Sci.U.S.A 4-30-1996;93(9):4284-4288. View abstract.

Kim, I. T., Park, Y. M., Shin, K. M., Ha, J., Choi, J., Jung, H. J., Park, H. J., and Lee, K. T. Anti-inflammatory and anti-nociceptive effects of the extract from Kalopanax pictus, Pueraria thunbergiana and Rhus verniciflua. J Ethnopharmacol. 2004;94(1):165-173. View abstract.

Lamlertkittikul, S. and Chandeying, V. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study. J Med Assoc Thai 2004;87(1):33-40. View abstract.

Lau, C. S., Carrier, D. J., Beitle, R. R., Howard, L. R., Lay, J. O., Liyanage, R., and Clausen, E. C. A glycoside flavonoid in Kudzu (Pueraria lobata): identification, quantification, and determination of antioxidant activity. Appl.Biochem.Biotechnol. 2005;121-124:783-794. View abstract.

Li X, Ni XQ Zhu YJ. Effect observation of puerarin plus heparin for senile unstable angina pectoris. Chinese Medicine of Factory and Mine 2002;15(5):420-421.

Wu, T. Q., Gu, N., and Wang, F. F. [Effect of ningxintong granule in treating patients of coronary heart disease with left ventricular diastolic dysfunction and qi-deficiency blood-stasis syndrome]. Zhongguo Zhong.Xi.Yi Jie.He.Za Zhi 2010;30(4):357-360. View abstract.

Bhargava P, Marshall JL, Dahut W, et al. A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers. Clin Cancer Res. 2001;7(12):3912-9. View abstract.

Coulibaly O, Thera MA, Koné AK, et al. A double-blind randomized placebo-controlled clinical trial of squalamine ointment for tinea capitis treatment. Mycopathologia. 2015;179(3-4):187-93. View abstract.

Garcia CA, Quiroz-Mercado H, Uwaydat S, et al. A phase I/II trial of intravenous squalamine lactate for treatment of choroidal neovascularization in age related macular degeneration (ARMD). Invest. Ophthal. Visual Sci. 2004;45(13):2362.

Herbst RS, Hammond LA, Carbone DP, et al. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Clin Cancer Res. 2003;9(11):4108-15. View abstract.

Kikuchi K, Bernard EM, Sadownik A, et al. Antimicrobial activities of squalamine mimics. Antimicrob Agents Chemother 1997;41:1433-8. View abstract.

Magainin Pharmaceuticals announces new research program for anti-angiogenesis agent - Squalamine - at Georgetown Univ Med Ctr. PRNewswire. www.prnewswire.com (Accessed 22 January 2000).

Magainin Presents Neuroblastoma Data for Squalamine at AACR Meeting. Available at: www.prnewswire.com (Accessed 3 April 2000).

Moore KS, Wehrli S, Roder H, et al. Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci U S A 1993;90:1354-8. View abstract.

Rose V, Schiller J, Wood A, et al. Randomized phase II trial of weekly squalamine, carboplatin, and paclitaxel as first line therapy for advanced non-small cell lung cancer. J. Clin. Oncol. 2004;22(14 suppl):7109.

Sills AK Jr, Williams JI, Tyler BM, et al. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res 1998;58:2784-92. View abstract.

Wroblewski JJ, Hu AY. Topical squalamine 0.2% and intravitreal ranibizumab 0.5 mg as combination therapy for macular edema due to branch and central retinal vein occlusion: An open-label, randomized study. Ophthalmic Surg Lasers Imaging Retina. 2016;47(10):914-923. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.